JPMorgan's $6 Billion Case of Lyme Disease
A central reason a bank known for its mastery of risk management could make such a huge mistake: One of its top executives, chief investment officer Ina Drew, 55, succumbed to the most human of problems: She got sick, apparently with Lyme Disease and, starting in 2010, missed out on chunks of time in the office, where she had been managing clashing personalities and internal rivalries and making sure that no one took on too much risk.
So clearly as Ms Drew was having time off sick in 2010 and 2011 with her Lyme Disease she was not cured by a few weeks antibiotics advocated by our IDSA Lyme Disease Guidelines.
Not only have these IDSA Lyme Disease guidelines wrecked havoc on thousands of patients lives around the World, because doctors adhering to those guidelines refuse ongoing treatment that for many of us have restored our health and lives, but also it would seem they may have been instrumental in the loss of Billions from JP Morgan's and thus contributed to the World banking crisis and recessions most countries are struggling with today.
It is way past time Lyme Disease and other Borreliosis and Tickborne Diseases were properly recognised for what they are capable of being, chronic, relapsing and persistent infections.
Perhaps Ms Drew with her background and now experience of Lyme Disease will put her weight into advocating for that recognition to come about. Science is there that shows the IDSA Guidelines to be too restricted with many uncertainties, it is having the will to look at the science and help the patients.